323 related articles for article (PubMed ID: 21896349)
21. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
[TBL] [Abstract][Full Text] [Related]
22. From global to regional: the importance of pneumococcal disease in Latin America.
de Quadros CA
Vaccine; 2009 Aug; 27 Suppl 3():C29-32. PubMed ID: 19540025
[TBL] [Abstract][Full Text] [Related]
23. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.
Aguiar SI; Brito MJ; Gonçalo-Marques J; Melo-Cristino J; Ramirez M
Vaccine; 2010 Jul; 28(32):5167-73. PubMed ID: 20558247
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
[TBL] [Abstract][Full Text] [Related]
25. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
Giglio N; Micone P; Gentile A
Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
[TBL] [Abstract][Full Text] [Related]
26. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic resistance in Latin America: a cause for alarm.
Valenzuela MT; de Quadros C
Vaccine; 2009 Aug; 27 Suppl 3():C25-8. PubMed ID: 19540634
[TBL] [Abstract][Full Text] [Related]
28. New insights on pneumococcal disease: what we have learned over the past decade.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
[TBL] [Abstract][Full Text] [Related]
29. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
30. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
32. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
33. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
Scheifele D; Halperin S; Pelletier L; Talbot J
Clin Infect Dis; 2000 Jul; 31(1):58-64. PubMed ID: 10913397
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children.
Bender JM; Ampofo K; Byington CL; Grinsell M; Korgenski K; Daly JA; Mason EO; Pavia AT
Pediatr Infect Dis J; 2010 Aug; 29(8):712-6. PubMed ID: 20661100
[TBL] [Abstract][Full Text] [Related]
35. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
[TBL] [Abstract][Full Text] [Related]
36. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
Motlová J
Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
[TBL] [Abstract][Full Text] [Related]
37. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
[TBL] [Abstract][Full Text] [Related]
38. [Invasive pneumoccal disease in children in Oslo 1998-2004].
Brauteset LV; Høiby EA; Syversen G; Surén P; Wathne KO
Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1380-3. PubMed ID: 18552897
[TBL] [Abstract][Full Text] [Related]
39. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
Zangeneh TT; Baracco G; Al-Tawfiq JA
Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
[TBL] [Abstract][Full Text] [Related]
40. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.
Kaplan SL; Barson WJ; Lin PL; Stovall SH; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
Pediatrics; 2010 Mar; 125(3):429-36. PubMed ID: 20176669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
